Investigating Oatp-Mediated Delivery of Statins to the Brain in Males and Females: Relevance to Neuroprotective Treatment for Ischemic Stroke
研究 Oatp 介导的他汀类药物向男性和女性大脑的递送:与缺血性中风神经保护治疗的相关性
基本信息
- 批准号:10682409
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-22 至 2024-10-21
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAgeAge YearsAlteplaseAnimalsBehavioralBiologicalBloodBlood - brain barrier anatomyBrainBrain IschemiaCause of DeathCerebral InfarctionCerebral cortexClinicalCoenzyme ACognitiveConfocal MicroscopyDataDevelopmentDrug TransportEdemaEffectivenessFDA approvedFemaleFibrinolytic AgentsGoalsGonadal Steroid HormonesHemorrhageHourIn SituIschemic StrokeLaboratoriesMale CastrationMarketingMeasuresMechanicsMediatingMenopauseMethodologyMethodsMiddle Cerebral Artery OcclusionModelingMotorNeurocognitiveNeurocognitive DeficitNeurologicNeurological outcomeNeuroprotective AgentsOATP TransportersOperative Surgical ProceduresOrganic Anion TransportersOutcomeOxidoreductasePerformancePerfusionPharmaceutical PreparationsPharmacological TreatmentPharmacotherapyPhase III Clinical TrialsPravastatinPropertyPublic HealthRattusRecovery of FunctionReperfusion InjuryResearch DesignRiskRoleSeveritiesSex DifferencesSprague-Dawley RatsStrokeStroke preventionTestingTherapeuticTimeTissuesUnited StatesUnited States National Institutes of HealthVariantWestern BlottingWomanWorkage groupatorvastatinbehavior testcognitive performanceendovascular thrombectomyexperienceexperimental studyfexofenadineimprovedindexinginhibitormalemenmolecular markermorris water mazeneurological recoveryneuroprotectionnovelobject recognitionpharmacologicpost strokepreclinical studyprotective effectprotein expressionsexstroke incidencestroke outcomestroke patientstroke therapytherapeutic effectivenesstherapeutically effectivetreatment strategyuptake
项目摘要
PROJECT SUMMARY
Stroke is the fifth leading cause of death in the United States. Approved stroke therapies are limited by narrow
treatment windows, the risk of hemorrhagic transformation, and reperfusion injury. Therefore, there is a critical
need for neuroprotective drugs that can improve post-stroke neurological performance. Currently, 3-hydroxy-3-
methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (i.e., statins) are given to stroke patients due to their
proven utility in improving cognitive and motor outcomes. Studies in our laboratory have uncovered a specific
biological mechanism that enables statins to be effective drugs for stroke treatment: transport across the blood-
brain barrier (BBB) via the endogenous uptake transporter organic anion transporting polypeptide 1a4 (Oatp1a4).
We have shown, for the first time, that Oatp-mediated transport is required for atorvastatin to reduce cerebral
infarction volume and improve sensorimotor performance at 24 h following transient middle cerebral artery
occlusion (tMCAO). We also observed increased atorvastatin uptake in female rats subjected to tMCAO as
compared with their age-matched male counterparts; however, it is unknown if these differences in Oatp-
mediated transport at the BBB cause variations in atorvastatin’s ability to prevent stroke progression and/or
worsening of neurocognitive deficits in the acute/subacute period. Our goals are to assess the role of sex as a
biological variable on statin transport in the ischemic brain and to determine how these differences affect statin
efficacy as stroke therapeutics. The central hypotheses of this F31 application are i) that functional
expression of Oatp1a4 at the BBB is different in males as compared to females following tMCAO; and ii)
that statin neuroprotective properties and/or their effects on post-stroke neurological outcomes are
influenced by sex-dependent differences in BBB Oatp1a4 activity. Two aims will test these hypotheses:
Aim 1: Investigate sex-dependent differences in Oatp1a4-mediated transport of statins at the BBB in
stroke. We will perform our studies in male and female SD rats using the tMCAO model. Oatp1a4 localization
and protein expression will be assessed using confocal microscopy and western blotting, respectively. Blood-to-
brain transport of statins will be measured using in situ brain perfusion, a state-of-the-art methodology to study
drug transport at the BBB.
Aim 2: Evaluate sex-dependent differences in statin-associated neuroprotection and functional
neurological recovery in stroke. In tMCAO operated male and female SD rats, we will use confocal microscopy
and western blot analysis to examine molecular biomarkers associated with neuroprotection. We will also assess
motor and cognitive performance in tMCAO-animals using robust behavioral tests (i.e., rotarod analysis, Morris
Water Maze, Novel Object Recognition test).
Overall, this project will provide critical mechanistic data on efficacy of statins as neuroprotective drugs for stroke.
Furthermore, this project directly aligns with NIH goals in studying sex as a biological variable in stroke.
项目概要
中风是美国第五大死因。批准的中风疗法受到狭窄的限制
治疗窗口、出血转化风险和再灌注损伤。因此,有一个关键的
需要可以改善中风后神经功能的神经保护药物。目前,3-羟基-3-
甲基戊二酰辅酶 A (HMG CoA) 还原酶抑制剂(即他汀类药物)由于其
已证明在改善认知和运动结果方面具有实用性。我们实验室的研究发现了一个特定的
使他汀类药物成为治疗中风的有效药物的生物学机制:跨血液转运
通过内源性摄取转运蛋白有机阴离子转运多肽 1a4 (Oatp1a4) 进入脑屏障 (BBB)。
我们首次证明,Oatp 介导的转运是阿托伐他汀减少脑损伤所必需的。
大脑中动脉短暂性损伤后 24 小时,可减少梗塞体积并改善感觉运动性能
闭塞(tMCAO)。我们还观察到接受 tMCAO 治疗的雌性大鼠阿托伐他汀摄取量增加
与同龄男性相比;然而,尚不清楚 Oatp 中的这些差异是否
BBB 介导的转运会导致阿托伐他汀预防中风进展的能力发生变化和/或
急性/亚急性期神经认知缺陷恶化。我们的目标是评估性别作为
缺血性大脑中他汀类药物转运的生物变量,并确定这些差异如何影响他汀类药物
作为中风治疗的功效。该 F31 应用的中心假设是 i) 函数
tMCAO 后,男性与女性 BBB 处 Oatp1a4 的表达不同;和 ii)
他汀类药物的神经保护特性和/或其对中风后神经系统结果的影响是
受 BBB Oatp1a4 活性的性别依赖性差异的影响。有两个目标将检验这些假设:
目标 1:研究 Oatp1a4 介导的他汀类药物在 BBB 转运中的性别依赖性差异
中风。我们将使用 tMCAO 模型对雄性和雌性 SD 大鼠进行研究。 Oatp1a4 本地化
和蛋白质表达将分别使用共聚焦显微镜和蛋白质印迹进行评估。血到-
他汀类药物的脑转运将使用原位脑灌注进行测量,这是一种最先进的研究方法
BBB 的药物运输。
目标 2:评估他汀类药物相关神经保护和功能的性别依赖性差异
中风的神经功能恢复。在 tMCAO 手术的雄性和雌性 SD 大鼠中,我们将使用共聚焦显微镜
和蛋白质印迹分析来检查与神经保护相关的分子生物标志物。我们还将评估
使用稳健的行为测试(即旋转分析、Morris
水迷宫、新物体识别测试)。
总体而言,该项目将为他汀类药物作为中风神经保护药物的功效提供关键的机制数据。
此外,该项目与 NIH 研究性别作为中风生物学变量的目标直接一致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erica Iris Williams其他文献
Erica Iris Williams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erica Iris Williams', 18)}}的其他基金
Investigating Oatp-Mediated Delivery of Statins to the Brain in Males and Females: Relevance to Neuroprotective Treatment for Ischemic Stroke
研究 Oatp 介导的他汀类药物向男性和女性大脑的递送:与缺血性中风神经保护治疗的相关性
- 批准号:
10535066 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 4.77万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 4.77万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 4.77万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 4.77万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 4.77万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 4.77万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




